AstraZeneca Withdraws Application For EU Approval For Ovarian-Cancer Medicine
September 21, 2016 at 12:31 PM EDT
AstraZeneca announced its decision to withdraw the Marketing Authorization Application submitted to the European Medicines Agency's Committee for Medicinal Products for Human Use in June 2015 for cediranib.
